Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-08

FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc. under the ANDA process, indicating an approved modification relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)